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Ischemic Stroke in Rats Enhances Bone Resorption in Vitro
We hypothesized that the formation and differentialtion of osteoclasts are accelerated and 
the potential of bone resorption is increased in the hemiplegic bone marrow in the early 
stage of stroke. We randomly divided white female Sprague-Dawley (SD) rats (n = 30) into 
two groups, stroke (n = 15) and sham group (n = 15). On the 7th day after stroke, after 
cutting away the epiphyses of the femurs and tibias, diaphyseal channels were flushed 
using α-minimum essential medium (α-MEM) and bone marrow cells were collected. Bone 
marrow stem cells, which were extracted from the femur and tibia, were cultured on the 
7th day after middle cerebral artery occlusion. We then estimated the ratio of non-
adherent cells to total bone marrow cells that included osteoclast precursor cells. After 
culturing these cells separately, cells that tested positive on the tartrate resistant acid 
phosphatase (TRAP) were counted and bone resorption was evaluated by using the OAAS
TM 
plate. In comparison to the control group, the stroke group showed a higher increase of 
non-adherent cells in the hemiplegic side bone marrow. In addition, after the primary 
culture, the stroke group showed an increased number of TRAP positive cells and a higher 
degree of bone resorption estimated by OAAS
TM plate. As a result, osteoclastogenesis and 
osteoclast differentiation are accelerated and the potential of bone resorption is increased 
in the hemiplegic bone marrow and these changes are detected as early as within the first 
week after middle cerebral artery occlusion in SD rats.
Key Words: Bone Resorption; Osteoclasts; Osteoporosis; Stroke 
Myung Eun Chung
1, Jong In Lee
2, 
Sun Im
3, and Joo Hyun Park
2
1Department of Rehabilitation Medicine, St. Paul’s 
Hospital, College of Medicine, The Catholic University 
of Korea, Seoul; 
2Deparment of Rehabilitation 
Medicine, Seoul St. Mary’s Hospital, College of 
Medicine, The Catholic University of Korea, Seoul; 
3Deparment of Rehabilitation Medicine, Bucheon 
St. Mary’s Hospital, College of Medicine, The Catholic 
University of Korea, Bucheon, Korea
Received: 28 March 2011
Accepted: 4 November 2011
Address for Correspondence:
Joo Hyun Park, MD
Department of Rehabilitation Medicine, Seoul St. Mary’s 
Hospital, College of Medicine, The Catholic University of Korea, 
222 Banpodae-ro, Seocho-gu, Seoul 137-701, Korea 
Tel: +82.11-9936-3907, Fax: +82.2-2258-2825
E-mail: drpjh@catholic.ac.kr 
http://dx.doi.org/10.3346/jkms.2012.27.1.84  •  J Korean Med Sci 2012; 27: 84-88
ORIGINAL ARTICLE
Rehabilitation & Sports Medicine
INTRODUCTION
Osteoporosis is the most common disease among metabolic 
bone diseases and can be defined clinically as existence of a frac-
ture, histomorphologically as reduction in bone matrix per unit 
volume, and epidemiologically as increased risk of fracture (1). 
Osteoporotic fracture increases with age and the frequency of  
it increases according to aging of society. In the United States, 
about 1.5 million osteoporotic fracture patients occur every year, 
resulting in an extremely high social medical expense of about 
18 billion dollars (2).
  According to recent reports, the bone mineral density of the 
hemiplegic limb is significantly lower than that of non-hemi-
plegic side, and the incidence of hip fracture increases by about 
2-4 times after stroke, among which more than 79% occur on the 
hemiplegic side (3-5). Sato et al. (6, 7) suggested two causes of 
osteoporosis by stroke. First, bone resorption increases by im-
mobilization from paralysis. Second, lack of nutrition and re-
duced exposure to sunlight bring deficiency of vitamin D, which 
induces osteoporosis. In this study, Sato et al. (6) demonstrated 
increase in bone resorption by increased serum carboxy-termi-
nal telopeptide of type I collagen (ICTP; a marker for bone resorp-
tion) in patients one week after stroke.
  Many studies using serum bone markers have reported on 
the induction of osteoporosis on the hemiplegic side since the 
initial stages of stroke, but there are no studies yet on the effect 
of stroke on osteoclast differentiation in bone marrow cells. We 
hypothesized that the formation and differentiation of osteo-
clasts are accelerated and the potential of bone resorption is in-
creased in the hemiplegic bone marrow in the early stage of 
stroke. To confirm this, we conducted a study with SD rats by 
extracting and culturing bone marrow cells in the femur and 
tibia after one week of stroke. 
MATERIALS AND METHODS
Animals and treatments
A group of 30 (12 weeks, 220-260 mg) white female Sprague-
Dawley rats were bred at a clean animal breeding room of the 
College of Medicine at the Catholic University of Korea. All ex-
perimental procedures were approved by the Animal Experi-
mental Committee of the Catholic University of Korea. The feed 
(Samyang Oil & Feed Co., Ltd., Seoul, Korea) containing 1.15% 
calcium and 0.75% phosphorous and water were supplied with-
out limits. 
  Subjects were randomly divided into the control and experi-
mental groups, and each group consisted of 15 rats. The experi-
mental group received ischemic stroke surgery and the control Chung ME, et al.  •  Ischemic Stroke in Rats Enhances Bone Resorption in Vitro
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group received a sham operation. Both groups were maintained 
at the same sleep-wake cycle with 12 hr light-dark cycle (light-
out 18:00-06:00). 
  The experimental protocol was approved by the institutional 
animal care and use committee at the College of Medicine, the 
Catholic University of Korea. 
Preparation of ischemic stroke rats
Ketamine (30 mg/kg) (Yuhan Co., Seoul, Korea) and xylazine 
hydrochloride (4 mg/kg) (Bayer Korea, Seoul, Korea) were used 
to anesthetize rats. While maintaining body temperature of 37°C 
± 1°C during the surgery, cerebral ischemia was induced using 
the method of Longa et al. (8). For the method of surgery, the 
central neck of rats was cut in supine position and the left com-
mon carotid artery was dissected. Following the common carotid 
artery, external carotid artery and internal carotid artery were 
separated for ligation of the common carotid artery and external 
carotid artery. The tip of monofilament nylon (4.0) was pushed 
into the common carotid artery bifurcation to block the middle 
cerebral artery. The same procedure was performed on the con-
trol group until the dissection of the carotid artery, but the rat 
was sutured without ligation of the artery. After ligation of the 
middle cerebral artery, permanent local ischemic stroke was 
confirmed using the following two methods. Three days after 
operation, neurologic examination was performed on the isch-
emic stroke and control rats, following the protocols used by 
Garcia et al. (9). Seven days after ischemic stroke, the femur and 
tibia were extracted, and the brain was taken out and placed for 
30 min in 2,3,5-Triphenyl-2H-tetrazolium chloride dye (Sigma 
Diagnostic, St. Louis, MO, USA). After 20 min of culturing at 37°C, 
it was fixed in 2% paraformaldehyde solution (Sigma Diagnos-
tic) to verify ischemic stroke (10). 
Culturing of bone marrow
Seven days after ischemic stroke, when all rats in the experimen-
tal and control groups were sacrificed, right femurs and tibias 
of the control group and right femurs and tibias of the experi-
mental group were extracted. The epiphyses of the femurs and 
tibias were cut away, and bone marrow was collected by flusing 
the diaphyseal channel with α-minimum essential medium (α- 
MEM). After centrifugation and counting the number of bone 
marrow cells, they were resuspended on α-MEM containing 
15% fetal calf serum. Cells were incubated for three hours un-
der 37°C vapor saturated atmosphere with 5% carbon dioxide 
in a tissue culture flasks (10
6 cells/cm
2). Then, the adherent cells 
and the non-adherent cells were separated.
Measurement of Tartrate-Resistant Acid Phosphatase 
(TRAP) positive cells
The ratio of the number of the non-adherent cells to bone mar-
row cells was measured and the non-adherent cells were dilut-
ed to a concentration of 1 × 10
6 cells/mL before moving to a cul-
ture dish. The cells were cultured on a 24-well plate (1 mL/well) 
in order to examine the number of TRAP positive cells. After 8 
days of culturing, cells were placed in citrate/aceton solution 
for 30 sec and dyed for one hour in a dark room of 37°C using 
Sigma Acid Phosphatase Leukocyte Kit (Sigma Diagnostic) to 
find TRAP positive cells.
Measurement of bone resorption
Among the non-adherent cells, 3 × 10
5 cells were cultured on an 
OAAS
TM plate (Osteogenic Core Technology, Cheonan, Korea) 
(1 mL/well) for evaluation of bone resorption. OAAS
TM plate is 
a product covered on the surface by calcium phosphate as a thin 
layer to allow measurement of bone resorption while culturing 
the osteoclast. 3 × 10
5 cells per well were cultured for 13 days. 
After cell culture, OAAS
TM plate was washed using distilled wa-
ter, dried and observed the percentage of resorbed area. The 
image was stored using a digital camera under optical micro-
scope and the area ratio of bone resorption to total area was eval-
uated using an image analysis program called Scion Image.
Statistical analysis 
Ratio of the non-adherent cells, the number of TRAP positive 
cells and the percentage of resorbed area on OAAS
TM plate were 
analyzed. Comparison between the control group that received 
sham operation and the hemiplegic side of the stroke group was 
analyzed using Mann-Whitney U test. Comparison between the 
hemiplegic side and the non-hemiplegic side of the experimen-
tal group was analyzed using Wilcoxon sign rank test. 
RESULTS
Throughout the experimental period, four rats died both in the 
experimental and control groups. The number of subjects was 
reduced to 22 rats for analysis of results, each group containing 
11 rats.
Body weight
Body weights before sham operation or ischemic stroke surgery 
and seven days after operations were 230.7 ± 9.5 g and 237.6 ±  
4.3 g in the control group and 231.9 ± 9.5 g and 235.4 ± 10.9 g in 
the experimental group, which showed no significant difference 
(P = 0.551). 
Verification of ischemic stroke 
Three days after ischemic stroke surgery, neurologic examina-
tion as proposed by Garcia et al. (9) was conducted. Scores of 
the control group and experimental group were 13.68 ± 0.5 and 
17.8 ± 0.4 points. A significant difference (P < 0.001) was shown 
between the two groups. Chung ME, et al.  •  Ischemic Stroke in Rats Enhances Bone Resorption in Vitro
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Measurement of osteoclastic precursor cell ratio
The ratio of the non-adherent cells containing osteoclastic pre-
cursor cells was 47.8% ± 12.5% for the control group, 64.2% ±  
13.8% on the hemiplegic side of the experimental group and 
48.2% ± 12.8% on the non-hemiplegic side of the experimental 
group. In comparison to the control group, significantly higher 
ratio was observed on the hemiplegic side of the experimental 
group (P = 0.013). There also was a significant difference be-
tween the hemiplegic side and the non-hemiplegic side of the 
experimental group (P = 0.001) (Fig. 1).
Measurement of TRAP positive cells
The number of TRAP positive cells was 38.1 ± 8.2 for the control 
group, 54.9 ± 11.1 for the hemiplegic side of the experimental 
group, and 42.6 ± 11.3 for the non-hemiplegic side of the exper-
imental group. Compared to the control group, the number was 
significantly higher (P = 0.001) on the hemiplegic side of the 
experimental group. In comparison of the hemiplegic and the 
non-hemiplegic side of the experimental group, significant dif-
ference was observed (P = 0.29) (Fig. 2, 3).
Measurement of bone resorption area
The percentage of resorbed area on an OAAS
TM plate was mea-
sured to be 0.08% ± 0.17% in the control group, 14.8% ± 6.5% 
on the hemiplegic side of the experimental group and 1.3% ±  
1.4% on the non-hemiplegic side of the experimental group. 
Compared to the control group, a significant difference was ob-
served on the hemiplegic side of the experimental group (P <  
0.001). Significant difference was also shown between hemiple-
gic and non-hemiplegic side of the experimental group (P =  
0.003) (Fig. 4, 5).
DISCUSSION
Monocytes and macrophage precursor cells in the bone mar-
row differentiate to preosteoclast. Then, TRAP gene is gradually 
expressed, and several cells fuse together to form a polykaryo-
cyte. The final form is an activated osteoclast (11). 
  In this study, the ratio of the non-adherent cells to total bone 
marrow cells was significantly increased on the hemiplegic side 
of the experimental group compared to the control group and 
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Fig. 1. Percentage of non-adherent cells from bone marrow. CTR, controls; S-HS, 
hemiplegic side of the stroke group; S-NHS, non-hemiplegic side of the stroke group. 
Data are the mean ± SEM. *P < 0.05 control.
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Fig. 2. Tartrate resistant acid phosphatase (TRAP) positive cells from bone marrow. 
CTR, controls; S-HS, hemiplegic side of the stroke group; S-NHS, non-hemiplegic 
side of the stroke group. Data are the mean ± SEM. *P < 0.05 control.
A C B 50 µm
Fig. 3. Photomicrographs of osteoclasts in primary culture obtained from bone marrow of rats, TRAP stain, magnification ×100. (A) Control. (B) Hemiplegic side of the stroke 
rats. (C) Non-hemiplegic side of the stroke rats. Chung ME, et al.  •  Ischemic Stroke in Rats Enhances Bone Resorption in Vitro
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the non-hemiplegic side. Although the total number of bone 
marrow cells did not differ by large, the ratio of the non-adher-
ent cells to total bone marrow cells increased. Since the non-ad-
herent cells containing osteoclastic precursors also contained 
monocytes and macrophage precursor cells, the above results 
suggest that compositional changes occur with a propensity of 
increased ratio of osteoclastic precursor cells in bone marrow 
from the early stages of stroke. The number of TRAP positive 
cells after osteoclastic precursors culture showed a 40% increase 
on the hemiplegic side of the MCA occlusion group compared 
to the control group. We cultured the same number of the non-
adherent cells, but a larger number of TRAP positive cells was 
measured for the hemiplegic side of the MCA occlusion group 
compared to the control group. This indicates that the formation 
and differentiation of osteoclasts in bone marrow are accelerat-
ed from the early stage of stroke. Bone resorption area measured 
after culturing the osteoclastic precursors on OAAS
TM plate was 
increased by a factor of over 100 in the hemiplegic side of isch-
emic stroke compared to the control group. The number of TRAP 
positive cells was about 40% higher in the experimental group 
than the control group, but a difference of over 100 times for bone 
resorption area measured on OAAS
TM plate showed an increased 
potential of osteoclastic activity in the MCA occlusion group.  
As such, the formation and differentiation of osteoclasts in the 
hemiplegic bone marrow are accelerated from the early stages 
of stroke, thereby increasing the potential of bone resorption 
and accelerating the development of osteoporosis on the hemi-
plegic side.
  According to recent studies, excessive bone loss is present in 
infectious disease. Activated T cells increase the expression of 
receptor activator of nuclear factor κB ligand (RANKL), and there-
by promote osteoclastic activity (12, 13). Acute post-stroke peri-
od is vulnerable to infection for humans as well as experimental 
animals. Therefore, the possible post-stroke infection may be 
another cause of promoting osteoclastic activity. 
  A recent study reported that 16.4%-38.5% of hip fracture pa-
tients have a past history of stroke (3). In stroke patients with uni-
lateral stroke and persisting paresis at the time of fracture, 62.5% 
have their fracture on the paretic side. Hip fracture is more com-
mon in patients with less severe stroke than in patients with more 
severe stroke because mobility is better in those with less severe 
stoke and they have more chance to fall down. This study sug-
gests that reduced bone density on the lower limb on the hemi-
plegic side as an important cause (3).
  Grano et al. (14) reported on the increased bone resorption 
and formation of osteoclasts in the bone marrow within five days 
of removal of weight bearing on rat hindlimb. Sato et al. (6) re-
ported on the increased biochemical marker which shows bone 
resorption one week after stroke. In accordance to the results 
from previous studies, we hypothesize that the increase in osteo-
clastogenesis in the bone marrow cells and bone resorption that 
were detected in this study, were also caused by reduced weight 
bearing from immobilization of the hemiplegic side. Looking at 
this, active weight bearing on the hemiplegic side from the ini-
tial stages of stroke should be an important therapeutic point in 
order to reduce the effect of immobilization. 
  This study has some limitations. Firstly, we demonstrated only 
the change of osteoclast differentiation and the potential of bone 
resorption in the early stage of stroke, because we speculated 
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Fig. 4. The percentage of mineral surface resorbed by osteoclasts on OAAS
TM plate. 
CTR, controls; S-HS, hemiplegic side of the stroke group; S-NHS, non-hemiplegic side 
of the stroke group. Data are the mean ± SEM. *P < 0.05 control.
A C B 200 µm
Fig. 5. Photomicrographs of pits formed by osteoclasts from rats, magnification ×25. (A) Control. (B) Hemiplegic side of the stroke group. (C) Non-hemiplegic side of the stroke 
group.Chung ME, et al.  •  Ischemic Stroke in Rats Enhances Bone Resorption in Vitro
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that the rate of bone loss in the early stage of stroke was proba-
bly accelerated with a disproportionate increase in bone resorp-
tion (15). However, osteoporosis is influenced not only by the 
changes of osteoclast differentiation and bone resorption, but 
also by the changes of osteoblast differentiation and bone for-
mation. Therefore, additional studies about the changes of osteo-
blast differentiation and bone formation might be needed. Sec-
ondly, the percentage of resorbed area on OAAS
TM plate was 
measured to be 0.08% in the control group, but this result was 
so small that it may be doubted whether the 3 × 10
5 cells cul-
tured on the plate were not enough to measure bone resortion 
area or an OAAS
TM plate was not adequate for measuring a tiny 
resorption area. Lastly, this study has another limitation from 
small sample size.
  Since osteoclastogenesis and osteoclast differentiation accel-
erate and bone resorption increases at the early stage of stroke, 
bone resorption inhibitors such as bisphosphonates might have 
the prevention effect against the osteoporosis on the hemiple-
gic limb (16). Poole et al. (17) reported that zoledronate therapy 
is associated with a reduction in osteoclastsic cell numbers. An-
other study showed that treatment with etidronate increases 
bone mineral density in chronically hospitalized patients with 
stroke, and may prevent hip fracture (18). Further studies are 
necessary to measure the effectiveness of prevention of the os-
teoporotic fracture on the hemiplegic side by the use of bisphos-
phonates in the early stage of stroke. Furthermore, additional 
studies are needed to estimate the amount of weight bearing 
time required in order to exert its preventive effect on osteopo-
rosis in the early stage of stroke. 
  In summary, this study demonstrates that osteoclastogenesis 
and osteoclast differentiation are accelerated and the potential 
of bone resorption is increased in the hemiplegic bone marrow 
and these changes are detected as early as within the first week 
after MCA occlusion in SD rats. After stroke, changes that lead to 
osteoporosis occur from the early periods of stroke; since hemi-
plegic patients have an increased propensity to have an unsta-
ble gait or movement pattern, falling down on the hemiplegic 
side can easily result in hip fractures. The results of this study 
emphasize the importance of active prevention and manage-
ment of osteoporosis from the early stages of stroke. 
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